A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here.
Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China.
The study of medicines derived from botanical sources.
A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.
Use of plants or herbs to treat diseases or to alleviate pain.
A genus of basiodiomycetous fungi in the family Coriolaceae. Members are known for infesting wood.
Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals.
Communications networks connecting various hardware devices together within or between buildings by means of a continuous cable or voice data telephone system.

In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism. (1/19)

Neutrophils are major culprits for the protease/antiprotease imbalance during various lung diseases, that is, chronic obstructive pulmonary disease, cystic fibrosis, idiopathic pulmonary fibrosis and adult respiratory distress syndrome. Thus, these cells are presently considered an ideal target for the pharmacologic control of tissue injury during these diseases. This study was planned in order to investigate if ambroxol and its precursor bromhexine are actually capable of preventing alpha-1-antitrypsin (A1AT) inactivation by stimulated neutrophils and possibly to look into the mechanisms underlying this event. Ambroxol inhibited the production of superoxide anion by activated neutrophils, whereas bromhexine had no inhibitory effect. Ambroxol decreased the production of hypochlorous acid (HOCl) from activated neutrophils with high efficiency, whereas bromhexine had a modest activity. Ambroxol and bromhexine were capable of limiting the chlorination of monochlorodimedon by HOCl, displaying the capacity of directly scavenging the oxidant. Ambroxol decreased the release of elastase and myeloperoxidase from activated neutrophils, whereas bromhexine was ineffective. Ambroxol prevented the A1AT inactivation by neutrophils, whereas bromhexine was completely ineffective. Among drugs currently available for in vivo use in humans, ambroxol is unique by virtue of its ability to prevent neutrophil-mediated A1AT inactivation via inhibition of HOCl production as well as HOCl scavenging. Also taking into account its capacity for curbing elastase release, the drug displays the potential to lessen the burden of oxidants/proteases and to increase the antiprotease shield at the site of inflammation. Thus, ambroxol appears to be a good candidate for raising attempts to develop new therapeutic histoprotective approaches to inflammatory bronchopulmonary diseases.  (+info)

Mediastinal pancreatic pseudocyst caused by obstruction of the pancreatic duct was eliminated by bromhexine hydrochloride. (2/19)

A 49-year-old man, who had a 30-year history of drinking the equivalent of 80 g of ethanol per day, underwent a detailed medical examination for cough and dyspnea. Chest-abdominal computed tomography and endoscopic retrograde pancreatography led to the diagnosis of a mediastinal pancreatic pseudocyst resulting from obstruction of the pancreatic duct by a protein plug. The pseudocyst rapidly improved with conservative treatment with camostat mesilate, H2-receptor antagonist and digestive enzymes. Although the patient abstained from alcohol for approximately 6 months, he resumed drinking, leading to recurrent attacks of pancreatitis. Bromhexine hydrochloride was then administered for 6 months, with the expectation that it would have a mucolytic effect on the pancreatic juice, resulting in improvement in the clinical symptoms, pancreatic enzymes and pancreatic exocrine function, as well as elimination of the protein plug. Bromhexine hydrochloride may be a new therapy for pathological states, such as alcoholic chronic pancreatitis, in which there is increased viscosity of the pancreatic juice because of elevated protein concentration, leading to protein plug formation and temporary blockage of the pancreatic duct.  (+info)

Synchronous germinomas in the pineal and suprasellar region. (3/19)

Synchronous primary intracranial germ cell tumors are rare. Only 5-10% of all germ cell tumors are found as synchronous lesion in pineal and suprasellar region. They are also known by the entity "double mid-line atypical teratoma". An 11-year-old male child presented with polyuria, polydipsia and features of raised intracranial tension. CT scan head revealed well-defined homogenously enhancing lesions in the pineal and suprasellar region. Histopathology examination showed the lesion to be of germ cell origin.  (+info)

Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study. (4/19)

BACKGROUND: A randomized double-blind placebo controlled clinical study was undertaken to investigate the safety and efficacy of a plant-based formulation (DCBT1234-Lung KR), which earlier through 2 trials was found to improve FEV1 and the quality of life of COPD patients. OBJECTIVE: The efficacy of DCBT1234-Lung KR was assessed using pulmonary function tests, arterial blood gas (ABG) analyses and the clinical symptoms of COPD in a 6-month study period against a matching placebo and a biomedical drug combination (salbutamol+theophylline+bromhexine). METHODS: One hundred and five subjects aged between 35 and 85 years with a smoking history of more than 20 pack years, showing little or no improvement in FEV1 upon a bronchial challenge of 200 microg of inhaled salbutamol and exhibiting ABG percentage of less than 85% of oxygen saturation were taken up for the study. The study had 3 arms viz., the plant-based formulation (DCBT1234-Lung KR), placebo and salbutamol (12 mg/day) plus theophylline (300 mg/day) plus bromhexine (24 mg/day). The end point of the study was determined as an improvement of FEV1 by 200 mL and/or increased ABG values (>90% PaO2) and clinical symptoms like dyspnoea, wheezing, cough, expectoration, disability, and sleep disturbances. RESULTS: DCBT1234-Lung KR patients showed statistically significant (95% level) improvement in FEV1 and PaO2 in comparison with salbutamol+theophylline+bromhexine and placebo patients. Twenty-three per cent of DCBT1234-Lung KR patients, 19% of salbutamol+theophylline+bromhexine group and 12% of placebo group patients showed the desired 200 mL improvement in FEV1 values in comparison with the other 2 arms. Improved PaO2 was observed in 15.4% of the DCBT1234-Lung KR patients while no improvement was seen with patients in any other arms. Symptoms like dyspnoea, wheezing, cough, expectoration, disability and sleep disturbances also significantly reduced in DCBT1234-Lung KR and the biomedical group patients, but not in the placebo arm. CONCLUSIONS: DCBT1234-Lung KR was equivalent, if not better than the present day treatment with salbutamol, theophylline and bromhexine combination in COPD patients and this was ascertained using FEV1 and ABG values.  (+info)

A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs. (5/19)

A 66-year-old man suffered from a drug-resistant, left-sided headache with autonomic signs, triggered by the supine position. The acromegalic facies initially suggested a possible increase in basal plasma levels of GH, but routine haematological controls excluded abnormal values of GH. Cerebral and facial CT scan and MRI did not detect any alterations in the nasal sinuses, except for a mucous cyst. Surgical ablation of the cyst did not alleviate the pain. Further endocrinological the pain. Further endocrinological tests demonstrated an increase of IGF-1 (somatomedin C), and another MRI scan of the sellar region confirmed the presence of a pituitary macroadenoma on the left paramedian side. After an initial improvement of the symptomatology due to trans-sphenoidal ablation of a benign GH-producing macroadenoma, the headache worsened again. Pain was well correlated with the increased plasma levels of IGF-1. The patient died suddenly for myocardial infarct.  (+info)

Pharmacokinetic interaction between cefaclor and bromhexine in healthy Chinese volunteers. (6/19)

OBJECTIVE: To determine the pharmacokinetic interaction between cefaclor and bromhexine in healthy Chinese volunteers. METHODS: Twelve subjects received a cefaclor (CEF) treatment, a bromhexine (BHX) treatment, and a co-treatment of CEF and BHX with a 3 x 3 Latin square design. The wash-out time between periods was 14 days. The plasma and urine drug concentrations of CEF and BHX were detected by HPLC-UV and LC/MS, respectively. RESULTS: All the 12 volunteers completed the study. There were no significant differences in AUC 0-t and Cmax of CEF in logarithm between the single administration group of CEF and the co-administration group of CEF with BHX. Two one sided t-test showed that CEF was bioequivalent in the 2 groups. There were no significant differences in tmax, MRT, t1/2, and Clr between the 2 groups. Vd/F was significantly lower in the single CEF group than in the co-administration group of CEF and BHX. There were no significant differences of AUC 0-t and Cmax of BHX in logarithm between the single administration group of BHX and the co-administration group of BHX with CEF. Two one sided t-test showed that BHX was bioequivalent in the 2 groups. There were no significant differences in tmax, MRT, t1/2, Vd/F, and Clr between the 2 groups. CONCLUSION: There is no significant pharmacokinetic parameter change in the drug absorption, metabolism, and excretion, but Vd/F of CEF significant increases in the co-administration of CEF with BHX. The co-administration of CEF and BHX has no adverse drug interaction. The increase of Vd/F may be a favorable drug interaction, which may be the mechanism of the synergistic effect of the 2 drugs.  (+info)

Anatomical suitability for endovascular AAA repair may affect outcomes following rupture. (7/19)

 (+info)

Tuberculosis should not be ignored in patients with peripheral gangrene. (8/19)

 (+info)

Bromhexine is a medication that is used to treat respiratory tract infections, such as bronchitis and sinusitis. It works by reducing the production of mucus in the airways, making it easier to cough up and clear. Bromhexine is available in oral solution, tablets, and syrup forms. It is usually taken two to three times a day, as directed by a healthcare provider. Common side effects of bromhexine include nausea, vomiting, and diarrhea. It is important to follow the dosage instructions provided by a healthcare provider and to inform them of any other medications you are taking before starting bromhexine.

In the medical field, "Drugs, Chinese Herbal" refers to a category of medications that are derived from plants, animals, and minerals found in China and other parts of East Asia. These medications are used to treat a wide range of conditions, including digestive disorders, respiratory problems, and pain. Chinese herbal medicine has a long history dating back thousands of years and is based on the principles of traditional Chinese medicine. It involves the use of various herbs, roots, and other natural substances that are combined to create a formula that is tailored to the individual patient's needs. Chinese herbal medicine is often used in conjunction with other forms of treatment, such as acupuncture and massage, to provide a holistic approach to healthcare. However, it is important to note that the use of Chinese herbal medicine can have potential side effects and interactions with other medications, so it is important to consult with a qualified healthcare provider before using these medications.

... is a mucolytic drug used in the treatment of respiratory disorders associated with viscid or excessive mucus. It was ... Bromhexine is intended to support the body's mechanisms for clearing mucus from the respiratory tract. It is secretolytic, ... Bromhexine is well established and tolerated. Barkacin Benadryl Chesty/Forte Bisolvon Brofentol Brofentol Plus Bromex Bromhexin ... Bromhexine is contained in various formulations, high and low strength syrups 8 mg/5 ml, 4 mg/5 ml, tablets and soluble tablets ...
... is a trade name for a medication whose active substances are: Bromhexine, a mucolytic agent. In addition, bromhexine ...
Examples are carbocisteine, ambroxol, and bromhexine. Expectorants are substances claimed to make coughing easier while ...
Both ambroxol and its parent drug bromhexine have been shown to induce autophagy in several cell types, and ambroxol was shown ... "Bromhexine-containing cough and cold medicines - risk of allergy and skin reactions" (PDF). Medicines Safety Update. ... Deretic V, Timmins GS (March 2019). "Enhancement of lung levels of antibiotics by ambroxol and bromhexine". Expert Opinion on ... Püschmann S, Engelhorn R (1978). "[Pharmacological study on the bromhexine metabolite ambroxol (author's transl)]". ...
The main ingredients found are guaifenesin and bromhexine hydrochloride. It is to be taken orally to provide relief from cough ...
Bromhexine, a serine protease inhibitor with mucolytic properties available over-the-counter in Europe, was originally derived ... "A reappraisal of the mucoactive activity and clinical efficacy of bromhexine". Multidisciplinary Respiratory Medicine. 12: 7. ...
... mucolytic cough medicine bromhexine, which is also being investigated as a possible treatment for COVID-19 itself as well. The ... is there a role for bromhexine as add-on therapy?". Internal and Emergency Medicine. 15 (5): 801-812. doi:10.1007/s11739-020- ...
Bromhexine, a synthetic compound imitating the molecular shape of vasicine[citation needed], is a common ingredient of cough ...
Adams, Holland, & Bostwick, 2008, p. 591 Mucoactive drugs include: acetylcysteine ambroxol ammonium chloride bromhexine ...
... bromhexine MeSH D02.092.146.271.100 - ambroxol MeSH D02.092.146.290 - benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(n,n- ... bromhexine MeSH D02.092.384.175.100 - ambroxol MeSH D02.092.471.200 - cystamine MeSH D02.092.471.245 - dibenzylchlorethamine ...
Combinations R05CA11 Levoverbenone R05CA12 Hederae helicis folium R05CA13 Cineole R05CB01 Acetylcysteine R05CB02 Bromhexine ...
... bromhexine) Buscopan / Buscapina (hyoscine butylbromide) Dulcolax (bisacodyl) Zantac (ranitidine)-75 and 150 mg tablets; 300 mg ...
Bromfenex Bromhexine (INN) Bromindione (INN) Bromisoval (INN) Bromociclen (INN) Bromocriptine (INN) Bromofenofos (INN) Bromofos ...
You have to enable JavaScript in your browsers settings in order to use the eReader.. Or try downloading the content offline. DOWNLOAD ...
Supplier of Bromhexine in Pudukkottai Tamil Nadu India, Bromhexine Manufacturer Pudukkottai, Wholesale Bromhexine Supplier, ...
LTD., is certified Manufacturer,Supplier and Exporter of Bromhexine HCL BP/EP located in Thane, Maharashtra, India. ... Bromhexine HCL BP/EP is used in the treatment of respiratory problems characterized by cough & hard phlegm. It works by ... Moreover, our provided Bromhexine HCL BP/EP can be obtained from us at nominal rates. ...
Comparative clinical trial with bromhexine. Acta Ther 1978;4:125-132.. * Bariffi, F. and Seccia, A. Ricerca controllata doppio- ... Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo. Acta Tuberc.Pneumol.Belg. 1979;70:71-80 ...
hydrochloride (C13H18Br2N2O) can be an dynamic N-desmethyl metabolite of bromhexine hydrochloride.. March 17, 2017 ... hydrochloride (C13H18Br2N2O) can be an dynamic N-desmethyl metabolite of bromhexine hydrochloride. administration the ...
Augmentation of tear production/secretion has been attempted with medications such as bromhexine and 3-isobutyl 1- ... although neither rose bengal staining nor ocular discomfort improved with the use of bromhexine. The mode of action is to ...
We initiated treatment with ciprofloxacin, carprofen, bromhexine, and β-glucan and fogged his living quarters twice daily with ...
Product Bronchotussine bromhexine cough Syrup OTC It is used as a mucolytic for the treatment of respiratory disorders ...
Bromhexine Elixir 120Ml. SALE 10% Rated 5.00 out of 5. ₹143.00. ₹128.70. ...
Bromhexine tablets 8 mg * 20 TEVA. € 5.68. Add to cart. * Ivermectin tablets 3 mg * 30 Expiration date: 11/2023. € 55.83. Add ...
Sunward Bromhexine 8mg tablets - 10 x 100s. 0 out of 5. RM100.00. Add to cart Add to Wishlist ...
... after his Covid-19 diagnosis in October-and the congestion medication bromhexine, which reduced death rates among hospitalized ...
The salts Bromhexine, Etophylline, Terbutaline Sulphate are involved in the preparation of Somavent Tablet. ...
We at " Alpha Drugs " are committed to improve peoples lives. Our aim is to provide patients with better access to high quality and cost effective medicines. Contributing towards better healthcare through innovation. ...
In this course, you will learn about most available medications in community pharmacy in a brief, simple and smart way
Bromhexine HCl. *Buckleys Chest Congestion. *Chest Congestion Childrens. *Chest Congestion Relief. *Chest Congestion Relief ...
主成分略述:ACETAMINOPHEN (EQ TO PARACETAMOL);;DEXTROMETHORPHAN HBR;;DL-METHYLEPHEDRINE HCL;;BROMHEXINE HCL;;CHLORPHENIRAMINE MALEATE ...
Bromhexine HCl. L392. M/s Davis Pharmaceutical Laboratories,. Islamabad-Pakistan. 2. Kof Relief Syp 100mL. (Reg, Export Only). ...
Our results indicate that bromhexine enhances fusion under some conditions. We therefore caution against the use of bromhexine ... Bromhexine, reportedly an inhibitor of TMPRSS2, is currently being tested in clinical trials against coronavirus disease 2019. ... Finally, we found that the TMPRSS2 inhibitor bromhexine, unlike the inhibitor camostat, was unable to reduce TMPRSS2-activated ... The related compound ambroxol, which similarly to bromhexine is clinically used as an expectorant, did not exhibit activating ...
Bromhexine Hydrochloride. Ingredients : Each 5 ml contains : Bromhexine Hydrochloride IP ......... 4 mg Flavoured syrup base ...
Bromhexine HCl Syrup.. B. No. DL087, M/D- 07/17, E/D-06/19, Mfd By- M/s Saar Biotech, NH-21A, Bhud Baddi, Distt. Solan (HP)- ... Redikuf (Bromhexine Hcl & Pseudoephedrine Hcl Tabs U.S.P.),. B.No. TRP-12854,M/D- 06/12,E/D- 05/14,Mfg By - Pro Laboratories (P ... Does Not Meet the Requirement of test for assay of Bromhexine HCl. Fugaat Medical store, Shop No. C-1/14, g.f. Yamuna Vihar, ... Bro-Zydex Expectorant 100 ml (Terbutaline Sulphate, Bromhexine, Guaiphenesin & Menthol Syrup),. B.No. JP-10104,M/D- 01/14,E/D- ...
VITABIOTICS koodiga NV20 20% tavahindadelt valik ⚡ Kiire tarne ➤ Tulge ja ostke e-apteegist!
Bromhexine Tablets 8mg *Bromocryptin Tablet B.P 2.5mg *Calcium carbonate Tablets 300mg ...
Bromhexine + Guaiphenesin + Menthol + Phenylephrine. Therapy. COUGH COLD PREPARATION. Check more medicines with composition as ...
Bromhexine hydrochloride 8mg/10mL; Guaiphenesin 200mg/10mL. Also contains Sucralose, Saccharin Sodium, Sorbitol and Sodium ...
Bromhexine is a derivative of the Adhatoda vasica and very effective as an expectorant of the upper and lower respiratory tract ... Bromhexine is a derivative of the Adhatoda vasica and very effective as an expectorant of the upper and lower respiratory tract ...
The salts Ammonium Chloride, Bromhexine, Diphenhydramine, Guaifenesin, Menthol are involved in the preparation of Zeet ...
Bromhexine (25mg to 50mg per day). Vitamins C (1000mg) and D (2000 u/d). Early treatment: Zinc (75mg to 150mg per day). ... Bromhexine (50mg to 75mg per day). Vitamins C (1000mg) and D (4000 u/d). Ancillary (prescription only):. Hydroxychloroquine ( ...
  • hydrochloride (C13H18Br2N2O) can be an dynamic N-desmethyl metabolite of bromhexine hydrochloride. (bioerc-iend.org)
  • The salts Bromhexine, Guaifenesin are involved in the preparation of Megatuss P Syrup. (medibuddy.in)
  • The salts Bromhexine, Etophylline, Terbutaline Sulphate are involved in the preparation of Somavent Tablet. (medibuddy.in)
  • injectable generation plus the mucolytic action of bromhexine that acts in the control of respiratory symptoms. (abbeyveterinarysupply.com)
  • Bromhexine HCL BP/EP is used in the treatment of respiratory problems characterized by cough & hard phlegm. (orexpharma.in)
  • We initiated treatment with ciprofloxacin, carprofen, bromhexine, and β-glucan and fogged his living quarters twice daily with F10 antiseptic solution (1:250 dilution) containing benzalkonium chloride and polyhexanide. (cdc.gov)
  • Ambroxol hydrochloride (AMB) and bromhexine hydrochloride (BRO) are classic expectorants and bronchosecretolytic pharmaceuticals. (bvsalud.org)
  • The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has started a safety review of medicines that contain ambroxol and bromhexine. (medscape.com)
  • Bromhexine is largely converted into ambroxol by the body, and some reports have associated bromhexine with allergic reactions. (medscape.com)
  • Question 1: How are ambroxol and bromhexine being used? (medscape.com)
  • PRAC Starts Review on Ambroxol, Bromhexine Meds - Medscape - Apr 11, 2014. (medscape.com)
  • Ambroxol is a metabolite of Bromhexine. (medeasy.health)
  • The popular bromhexine drops enriched with essential oils, without alcohol, sugar and dyes, liquefy and dissolve mucus in respiratory diseases and facilitate its expectoration. (senimed.cz)
  • O munadoko pupọ bi mucolytic expectorant ti o mu yomijade ti iṣan pọ si ati dinku ni iki nitori apapọ agbara ti (Menthol ati Bromhexine).O tun jẹ itọkasi lati tọju awọn aami aisan ti o waye lati awọn akoran atẹgun gẹgẹbi iṣoro ni mimi ati sini ninu Adie.O ṣe iranlọwọ pupọ lati dinku ipa ti aapọn ajesara lẹhin aapọn Aapọn-Ikọaláìdúró, ipa sinusitis ikọ-fèé ati aapọn ooru. (joycomevet.com)
  • No, Ascoril+ cough syrup contains terbutaline, bromhexine and Guaifenesin. (pulseplus.in)
  • Natural Medicines Comprehensive Database (La Base Exhaustiva de Datos de Medicamentos Naturales) clasifica la eficacia, basada en evidencia científica, de acuerdo a la siguiente escala: Eficaz, Probablemente Eficaz, Posiblemente Eficaz, Posiblemente Ineficaz, Probablemente Ineficaz, Ineficaz, e Insuficiente Evidencia para Hacer una Determinación. (medlineplus.gov)
  • We initiated treatment with ciprofloxacin, carprofen, bromhexine, and β-glucan and fogged his living quarters twice daily with F10 antiseptic solution (1:250 dilution) containing benzalkonium chloride and polyhexanide. (cdc.gov)
  • After two years, in 1980, the company had launched formulations of Bromhexine for the first time in India. (angelone.in)